Premium
C. parvum treatment of transplanted rat tumours of spontaneous origin
Author(s) -
Willmott N.,
Pimm M. V.,
Baldwin R. W.
Publication year - 1979
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.2910240309
Subject(s) - fibrosarcoma , mammary carcinoma , carcinoma , mammary gland , pathology , biology , stimulation , skin tumours , cancer research , medicine , cancer , endocrinology , breast cancer
C. parvum (Wellcome CN6134) has been examined for suppression of a range of transplanted rat tumours of spontaneous origin. With five tumours (three mammary carcinomas and two fibrosarcomas) growth of comparatively high cell inocula (with respect to the minimum for growth in control rats) was suppressed by admixture with the vaccine. Equivalent dry weights of Glaxo, Pasteur or Connaught BCGs were relatively ineffective. Intralesional injection of C. parvum into three established tumours (two mammary carcinomas and one fibrosarcoma) retarded development of only one, the mammary carcinoma Sp4. With three mammary carcinomas and one fibrosarcoma, active specific immune stimulation with vaccines of viable or irradiated cells admixed with C. parvum was again consistently effective only with carcinoma Sp4, and this tumour was also susceptible to intradermal but not intravenous treatment with C. parvum alone.